4/15
04:12 pm
amlx
Amylyx Pharmaceuticals Sets Up Q3 Phase 3 Avexitide Data Readout, Eyes Potential 2027 Launch [Yahoo! Finance]
Medium
Report
Amylyx Pharmaceuticals Sets Up Q3 Phase 3 Avexitide Data Readout, Eyes Potential 2027 Launch [Yahoo! Finance]
4/9
07:54 pm
amlx
Did Amylyx Pharmaceuticals, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Medium
Report
Did Amylyx Pharmaceuticals, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
4/8
09:00 am
amlx
Amylyx Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference
Low
Report
Amylyx Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference
3/31
07:40 am
amlx
Amylyx Pharmaceuticals (AMLX) Winds Up Avexitide Phase 3 Lucidity Trial Enrollment [Yahoo! Finance]
Medium
Report
Amylyx Pharmaceuticals (AMLX) Winds Up Avexitide Phase 3 Lucidity Trial Enrollment [Yahoo! Finance]
3/28
07:42 pm
amlx
Is LUCIDITY Trial Completion in Post-Bariatric Hypoglycemia Altering The Investment Case For Amylyx Pharmaceuticals (AMLX)? [Yahoo! Finance]
Medium
Report
Is LUCIDITY Trial Completion in Post-Bariatric Hypoglycemia Altering The Investment Case For Amylyx Pharmaceuticals (AMLX)? [Yahoo! Finance]
3/25
08:03 am
amlx
Amylyx Pharmaceuticals (AMLX) had its "buy" rating reaffirmed by HC Wainwright. They now have a $34.00 price target on the stock.
Low
Report
Amylyx Pharmaceuticals (AMLX) had its "buy" rating reaffirmed by HC Wainwright. They now have a $34.00 price target on the stock.
3/24
07:00 am
amlx
Amylyx Pharmaceuticals Announces Completion of Enrollment in Pivotal Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia
Low
Report
Amylyx Pharmaceuticals Announces Completion of Enrollment in Pivotal Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia
3/19
10:21 am
amlx
Amylyx Pharmaceuticals (AMLX) had its price target raised by Guggenheim from $25.00 to $30.00. They now have a "buy" rating on the stock.
Low
Report
Amylyx Pharmaceuticals (AMLX) had its price target raised by Guggenheim from $25.00 to $30.00. They now have a "buy" rating on the stock.
3/3/2026
07:00 am
amlx
amylyx pharmaceuticals, inc.
IN-LINE
Report
-4.3%
amylyx pharmaceuticals, inc.
11/6/2025
07:00 am
amlx
amylyx pharmaceuticals, inc.
BEAT
Report
-11.2%
amylyx pharmaceuticals, inc.
8/7/2025
07:00 am
amlx
amylyx pharmaceuticals, inc.
MISS
Report
-6.7%
amylyx pharmaceuticals, inc.
5/8/2025
07:00 am
amlx
amylyx pharmaceuticals, inc.
BEAT
Report
-6.0%
amylyx pharmaceuticals, inc.
3/26
03:42 pm
amlx
Form SCHEDULE 13G/A Amylyx Pharmaceuticals, Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G/A Amylyx Pharmaceuticals, Filed by: VANGUARD GROUP INC
3/24
07:11 am
amlx
Form 8-K Amylyx Pharmaceuticals, For: Mar 24
Low
Report
Form 8-K Amylyx Pharmaceuticals, For: Mar 24
3/9
04:00 pm
amlx
Form 4 Amylyx Pharmaceuticals, For: Mar 05 Filed by: Bedrosian Camille L
Medium
Report
Form 4 Amylyx Pharmaceuticals, For: Mar 05 Filed by: Bedrosian Camille L
3/9
04:00 pm
amlx
Form 4 Amylyx Pharmaceuticals, For: Mar 05 Filed by: Cohen Joshua B
Medium
Report
Form 4 Amylyx Pharmaceuticals, For: Mar 05 Filed by: Cohen Joshua B
3/9
04:00 pm
amlx
Form 4 Amylyx Pharmaceuticals, For: Mar 05 Filed by: FRATES JAMES M
Medium
Report
Form 4 Amylyx Pharmaceuticals, For: Mar 05 Filed by: FRATES JAMES M
3/9
04:00 pm
amlx
Form 4 Amylyx Pharmaceuticals, For: Mar 05 Filed by: Mazzariello Gina
Medium
Report
Form 4 Amylyx Pharmaceuticals, For: Mar 05 Filed by: Mazzariello Gina
3/9
04:00 pm
amlx
Form 4 Amylyx Pharmaceuticals, For: Mar 05 Filed by: Klee Justin B.
Medium
Report
Form 4 Amylyx Pharmaceuticals, For: Mar 05 Filed by: Klee Justin B.
3/4
04:00 pm
amlx
Form 4 Amylyx Pharmaceuticals, For: Mar 02 Filed by: Bedrosian Camille L
Medium
Report
Form 4 Amylyx Pharmaceuticals, For: Mar 02 Filed by: Bedrosian Camille L
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register